Earlier this year, the Trump administration rejected a proposal to expand Medicare coverage to include anti-obesity drugs , a move that would have added $40 billion to taxpayer expenditures over ten years
GlycoMimetics (NASDAQ: GLYC) shares nearly tripled, zooming 188% from 17 cents to 49 cents Tuesday after the company announced it had agreed to be acquired by privately held Crescent Biopharma for an undisclosed amount
We all know whycaffeine works wonders as an acute energy supplement
Wansleeben C, Feitsma H, Montcouquiol M, Kroon C, Cuppen E, Meijlink F
Review the five biotypes Folate Receptor Antibodies Folinic acid may involve a different clinical question when folate transport into the brain is impaired
Applying the Bradford Hill criteria in the 21st century: How data integration has changed causal inference in molecular epidemiology